SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-021390
Filing Date
2017-04-21
Accepted
2017-04-21 06:10:58
Documents
5
Period of Report
2017-06-14
Effectiveness Date
2017-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A v464551_def14a.htm DEF 14A 465154
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC v464551_proxycard-1.jpg GRAPHIC 712023
5 GRAPHIC v464551_proxycard-2.jpg GRAPHIC 369478
  Complete submission text file 0001144204-17-021390.txt   1956156
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34058 | Film No.: 17774153
SIC: 2834 Pharmaceutical Preparations